A Phase I, Multicenter, Open-Label Study of Oral ABL001 in Patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
NOT ENROLLING
Trial ID:
NCT02081378 Protocol # :
14-117
Phase
I
Disease Sites
Lymphoid Leukemia
Myeloid and Monocytic Leukemia
Leukemia, other
Principal Investigator
DeAngelo, Daniel, J
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #14-117
14-117